到2029年市场规模和未来增长

Global Vagus Nerve Stimulation Market

市场规模（十亿美元）

CAGR : 9.80 %

USD 576.31 Billion USD 1,217.51 Billion 2025 2033

Forecast Period	2026 –2033
Market Size (Base Year)	USD 576.31 Billion
Market Size (Forecast Year)	USD 1,217.51 Billion
CAGR	9.80 %
Major Markets Players	Liva Nova PLC (U.K.) Medtronic plc (爱尔兰) Boston科学公司 (U.S.) Abbott实验室 (U.S.) Nevro公司 (U.S.)

全球真空神经刺激市场划分,按产品类型(可栽培的VNS装置和外部VNS装置)、生物材料(陶瓷、金属和多美)、应用(Pain管理、癫痫缉获、肥胖管理、抑郁和焦虑等)、病人类型(Adults、小儿科和老年科)、终端用户(医院、门诊外科中心、专科中心等)、分销渠道(Direct Tender、零售销售等) -- -- 2033年之前的行业趋势和预测

真空神经刺激市场概览

真空神经刺激市场的价值2025年5763.1亿美元预计将达到到2033年1,217.51亿美元,生长在一个2026-2033年CAGR为9.80%编辑真空神经刺激市场神经功能障碍的日益普遍、神经调节疗法的日益采用、可植入性和非侵入性刺激技术的进步、以及跨越癫痫、抑郁症、偏头痛和其他神经病症的应用范围的扩大,正在经历持续的成长。

抗治疗性癫痫、严重抑郁症和其他神经系统疾病,加上对替代治疗方案的需求日益增加,这些负担日益加重,这正鼓励保健提供者采用反复无常的神经刺激技术。植入式和非侵入式活性神经刺激装置作为有效的治疗方法,正在获得牵引力,可以改善病人的结果,减少对常规疗法的依赖,并提供长期的症状管理。此外,在个性化神经调节、可穿戴刺激装置和最低侵入性技术方面的持续进步,正在扩大临床应用,支持发达和新兴保健市场的市场增长。

主要市场趋势和见解

北美在Vagus Nerve刺激市场占据了主导地位,2025年收入份额最大,为38.2%,主要神经调节设备制造商的强大存在、先进的保健基础设施、高水平采用可植入神经刺激疗法以及越来越多地使用VNS治疗癫痫和耐治疗抑郁症。本区域还受益于有利的偿还框架、神经系统紊乱率的上升以及对先进神经技术研究的持续投资。
可植入的VNS装置部分在2025年占了78.6%的市场份额,因为这些设备在临床上广泛用于治疗耐药性癫痫和耐药性抑郁症。
2026年至2033年,亚太区域的CAGR增长最快,为8.1%,其主要原因是神经系统疾病日益普遍,获得先进保健技术的机会增加,保健支出增加,中国、印度、日本和韩国等国越来越多地采用神经调节疗法。专科医院的扩大和对替代神经疗法的认识的提高正在进一步加快市场增长。
外部VNS设备预计将是增长最快的产品类型,在2026年至2033年注册的CAGR为9.2%,其驱动力是:对非侵入性神经调节疗法的需求增加,病人更容易被采纳,程序要求降低,抑郁症、疼痛管理和偏头痛治疗方面的研究应用不断增长. 便携式和方便用户的外部刺激装置的开发进一步支持了部分扩展。
由于长期对抗药性癫痫患者使用VNS疗法,2025年癫痫的癫痫患者在Vagus Nerve刺激市场中占了45.7%的收入份额。癫痫发作率上升,对形容词疗法的认识不断提高,对抗震药反应不足的患者越来越多地采用可植入的VNS系统,这些都推动了市场的增长。

市场大小和预测

全球市场价值(2025):576.31美元 10亿
预期市场价值(2033):1217.51美元 10亿
CAGR预测(2026-2033):9.80%
2025年主要区域:北美
最快增长区域:亚太

报告范围和真空神经刺激市场分块

属性	模糊神经刺激键市场透视
覆盖部分	按产品类型:可植入的真空神经刺激设备,和外真空神经刺激设备生物材料:陶瓷、金属和多聚体通过应用程序 :疼痛管理、癫痫发作、肥胖管理、抑郁症和焦虑等按患者类型 :成人、小儿科和老年科最终用户:医院,门诊外科中心、专科中心等按发行频道 :直接招标、零售等
涵盖国家	北美 · 美国。加拿大墨西哥欧洲德国法国英国。荷兰瑞士比利时 · 俄罗斯 · 意大利 • 西班牙土耳其 · 欧洲其他地区亚太中国 * 日本 • 印度韩国新加坡马来西亚澳大利亚泰国印度尼西亚菲律宾亚太其他地区中东和非洲沙特阿拉伯 · 美国南非 • 埃及 • 以色列中东其他地区和非洲南美洲 • 巴西阿根廷南美洲其他地区
关键市场玩家	• Liva Nova PLC(联合王国) • Medtronic plc(爱尔兰) • 波士顿科学公司(美国) • 阿博特实验室(美国) • Nevro公司(美国) • 电子Core股份有限公司(美国) • Setpoint医疗公司(美国) • Inspire医疗系统公司(美国) • 生物控制医疗(以色列) • 微型运输公司(美国) • Cerbomed GmbH(德国) • Parasym有限公司(英国) • Nalu医疗公司(美国) • NeurAxis股份有限公司(美国) • 真空神经刺激疗法(美国) • 创新卫生解决方案(美国) • Neurosigma公司(美国) • ReShape生命科学公司(美国) • Cyberonics Inc.(美国) • 刺激波技术公司(美国) • 突触生物医学公司(美国) • GTX医疗(荷兰) • Neuropace公司(美国) • Axonics有限公司(美国) • Saluda医药有限公司(澳大利亚) • 北京PINS医疗有限公司(中国) • 江苏奥克森斯医疗技术有限公司(中国)
市场机会	· 越来越多地采用非侵入性真空神经刺激技术扩大除癫痫和抑郁以外的应用新兴保健市场的增长机会
添加数据信息集的值	除了对市场价值,增长率,分化,地域覆盖,主要角色等市场情景的深刻认识外,由"数据桥市场研究"负责的市场报告还包括深入的专家分析,地域代表性的公司生产和能力,经销商和合作伙伴的网络布局,详细更新的价格趋势分析和供应链和需求赤字分析等.

真空神经刺激市场趋势

趋势:越来越多地采用非侵入性神经调节技术

全球多变神经刺激(VNS)市场正日益转向先进的神经调节解决方案,特别是非侵入性和对病人友好的刺激技术。保健提供者和研究人员正在越来越多地探索除癫痫以外的VNS应用,包括抑郁症,焦虑症,疼痛管理,炎症控制和肥胖症管理等. 外部VNS设备的开发,包括外相活性神经刺激(tVNS)系统,正在通过减少外科植入的需要来扩大治疗的可获性. 临床研究活动不断增多,对生物电子医学的兴趣不断提高,这进一步加速了活泼神经刺激技术的创新. 例如,ElectroCore等公司围绕非侵入性活性神经刺激平台,为神经和炎症提供了更多的研究和商业化努力,支持更广泛地采用基于VNS的疗法。

真空神经刺激市场动态

关键市场驱动力:神经病和精神病发病率上升

神经系统疾病,包括癫痫、抑郁症和慢性疼痛状况的全球负担日益加重,是驱动对活性神经刺激疗法需求的主要因素。 VNS为抗药性癫痫和耐治疗性抑郁症患者建立了临床应用,常规疗法可能提供有限的好处. 世界卫生组织认为,神经系统疾病是全世界残疾的主要原因之一,增加了对先进治疗方法的需求。在癫痫管理中越来越多地采用可植入的VNS设备,在心理健康应用中扩大支持VNS的临床证据,都鼓励保健提供者将神经调节疗法纳入治疗途径. 此外,设备编程、刺激准确性、电池效率以及最低侵入性植入技术方面的进步正在改善病人的结果和支持市场增长。

关键限制/挑战:可植入的VNS设备成本高和患者接触有限

对Vagus Nerve刺激市场的一个重大挑战是,可植入的VNS系统、外科植入程序和长期病人监测费用高昂。可植入装置需要专业的外科专业技术、后续编程和保健基础设施,这可以限制在成本敏感的市场和获得高级神经护理的机会有限的地区采用。此外,某些国家的报销限制,以及需要专门的神经学家和神经外科医生,都对广泛采用造成了障碍. 尽管VNS已经证明了临床效益,但与传统疗法相比,入侵植入和高治疗成本的要求仍然是影响市场渗透的关键因素,特别是在新兴经济体。

关键市场机会:扩大VNS的应用,超越癫痫和先进数字保健技术的一体化

在传统的癫痫治疗之外扩大活泼神经刺激应用为市场参与者提供了巨大的增长机会. 增加对抑郁症、焦虑症、肥胖症管理、炎症和疼痛障碍的VNS的研究正在扩大这些装置的治疗范围。外部VNS设备、可穿戴的刺激技术以及数字监测平台的开发为更方便和个性化的治疗方法创造了机会。例如,临床研究探讨了偏头痛和心理健康状况的非侵入性VNS方法,支持该领域的持续创新。此外,与人工智能、远程病人监测和个性化刺激算法相结合,可以改进治疗优化,使医院、专科中心和家庭护理场所能够更广泛地采用。

真空神经刺激市场范围

活性神经刺激市场根据产品类型、生物材料、应用、病人类型、最终用户和分销渠道进行分解。

按产品类型

根据产品类型,Vagus Nerve刺激市场被分入可植入的VNS装置和外部VNS装置. 可植入的VNS装置部分在2025年占了78.6%的市场份额,因为这些设备在临床上广泛用于治疗耐药性癫痫和耐药性抑郁症。这些装置通过外科植入系统提供持续的电刺激,可以进行长期疾病管理和个性化治疗调整. 该分会得益于强大的临床证据,监管批准,以及神经学家和神经外科医生的广泛接受. 神经系统疾病日益普遍,保健开支增加,以及越来越多地采用先进的神经调节疗法,这些都有助于扩大市场。此外,电池性能、编程能力和装置小型化方面的技术改进正在增强病人的结果并改进长期装置的可靠性。越来越多的专门神经护理中心和提高对VNS疗法的认识,进一步加强了全球可植入装置的主导地位。

由于对非侵入性神经调节疗法的需求增加和对患者友好治疗替代品的偏好增加,预计外部VNS设备部分在2026年至2033年的CAGR增长最快,为9.2%。外部VNS设备消除了外科植入的需要,使寻求安全和方便的刺激疗法的患者更容易获得这些设备。该部分在疼痛管理,抑郁,焦虑,偏头痛治疗,肥胖管理等应用中获得了牵引力. 在可穿戴技术、便携式设备开发和家庭保健解决方案方面的进步正在加速采用。越来越多的研究活动正在扩大临床应用。此外,降低程序费用、改善病人遵守规定情况并更加重视个性化的数字保健解决方案,预计在预测期间将推动迅速增长。

生物物质

在生物材料的基础上,Vagus Nerve刺激市场被分解成陶瓷,金属和聚合物. 聚合物部分在2025年占据了42.3%的市场份额,因为它广泛用于隔热层、防护涂层和VNS设备的灵活组件。聚合物材料因其优良的生物相容性,轻量级特征,灵活性,能承受长期的植入条件而被广泛取用. 这些材料有助于减少组织刺激,改善慢性刺激疗法期间患者的舒适度. 对耐用和病人安全植入装置的需求日益增加,这鼓励制造商注重先进的聚合物技术。该部分还得益于医疗级聚合物的持续创新,提高了设备的寿命和可靠性. 对癫痫、抑郁和慢性神经紊乱越来越多地采用可植入的神经调节系统,进一步支持聚合生物材料的领先地位。

陶瓷部分预计将在2026至2033年的8.6%的CAGR中增长最快,因为先进可移植医疗器械对高耐用、抗腐蚀和生物相容材料的需求日益增加。陶瓷材料提供了出色的机械强度,化学稳定性,以及与生物环境的相容性,使其适合下一代神经调节技术. 对生物材料研发的投资不断增加,这鼓励在医疗植入中使用先进的陶瓷。此外,陶瓷制造技术的改进正在提高材料性能并扩大其在可植入刺激系统的应用。日益注重改善植入安全,减少不良组织反应并延长装置寿命,预计将为以陶瓷为主的VNS组件创造出新的生长机会.

通过应用程序

根据应用,Vagus Nerve刺激市场被划分为疼痛管理,癫痫发作,肥胖管理,抑郁和焦虑等. 2025年,受抗药性癫痫病人的VNS疗法既定临床应用的推动,癫痫缉获量占了市场的45.7%。 VNS被广泛采用为通过抗震药不能取得足够控制的患者的形容词疗法. 全球癫痫病发病率的上升、对替代神经治疗方法的认识的提高、以及支持VNS有效性的强有力的临床证据,正在推动部分增长。保健提供者越来越多地将VNS设备纳入癫痫管理战略,因为他们有能力提供持续的刺激和改进扣押控制。扩大专门癫痫中心,并推广可植入刺激技术,进一步支持世界各地的收养。

2026年至2033年的CAGR增长9.0%,预计抑郁症和焦虑症的增长最快,这是由于心理健康障碍日益普遍,对抗治疗性抑郁症替代治疗方案的需求也日益增加。越来越多的临床研究对精神病的VNS疗法进行评估,正在扩大这些装置的应用范围。常规抗抑郁药疗法的局限性越来越大,这鼓励人们关注基于神经调节的解决方案。刺激技术、个性化治疗方案以及非侵入性VNS方法方面的进步正在改善治疗的可获性。心理健康意识的提高、保健投资的增加以及创新神经疗法的推广,预计将加快这一部门的增长。

按患者类型

根据病人类型,Vagus Nerve刺激市场分为成人、小儿科和老年科。由于成年人患癫痫、抑郁和慢性神经疾病的比例较高,2025年成年人占市场主导份额为67.4%。由于诊断率较高,有专门的治疗设施可用,而且采用可植入的神经调节装置较多,成人患者是VNS治疗的最大用户基础. 提高保健提供者对VNS福利的认识正在改善治疗的采用。长期临床数据支持治疗有效性的提供进一步加强了医生的信心. 此外,不断增加的保健开支和神经护理基础设施的扩大正在支持成人病人收养的持续增长。

2026年到2033年,由于老年人口老龄化和老年人神经和精神疾病发病率上升,老年病区将增长8.4%。老年人患有癫痫、抑郁和慢性疼痛等高发病率,对先进的治疗方法产生了更大的需求。改善获得保健服务的机会并更加重视与年龄有关的疾病管理,有助于收养。开发更安全和更方便病人的VNS技术正在提高老年人的适宜性。预计越来越重视改善生活质量和管理慢性神经病,将推动分块扩张。

按终端用户

在最终用户的基础上,Vagus Nerve刺激市场分为医院、流动外科中心、专科中心等。 2025年,医院部分占市场支配地位,占52.9%,有先进的外科基础设施、专门的神经科和受过培训的保健专业人员。医院仍然是VNS植入程序、病人评估、设备编程和长期监测的主要地点。该部分受益于对高级神经学和神经外科设施增加投资。在癫痫和抑郁症治疗中越来越多地采用可植入的VNS设备,这进一步增加了医院的需求。此外,强有力的报销支助和多学科护理小组的提供正在加强医院的主导地位。

2026至2033年的CAGR增长8.7%,预计流动外科手术中心增长最快,原因是向门诊程序和成本效益高的保健提供模式的转变日益增加。由于手术时间较短,住院要求减少,病人的方便程度提高,救护车中心越来越重要。越来越多地采用最低侵入性植入程序,有助于扩大这些设施。对专科门诊中心的投资增加和外科技术的改进正在加速采用。预计这一部分将受益于注重降低治疗费用、同时保持患者优质结果的保健系统。

按发行频道

以发售渠道为基础,Vagus Nerve刺激市场被分入直接招标,零售销售等. 2025年,由于医院、政府保健系统和专科医疗机构开展了强有力的采购活动,直接招标部分占了市场的48.6%。直接招标采购使保健组织能够通过既定的供应商关系和批量协议获得先进的VNS设备。该部分受益于结构化采购程序、长期合同以及保健设施越来越多地采用先进的神经调节技术。扩大保健基础设施并增加政府在神经护理方面的投资,进一步支持了部门增长。此外,直接采购渠道有助于确保可靠的设备可用性和技术支助。

零售部分预计将在2026年至2033年达到8.5%的CAGR增长最快,其动力是外部VNS设备供应量的增加和越来越多地采用家庭神经调节解决方案。消费者意识的提高和对非侵入性疗法的需求的增加正在扩大零售机会。在线保健平台和特殊医疗器械经销商的增长正在改善患者的无障碍环境。此外,越来越多的便携式刺激装置用于疼痛管理和健康应用,正在支持零售扩展。向以病人为中心的保健模式和个性化治疗解决方案的转变预计将进一步加快这一分销渠道的增长。

真空神经刺激市场区域分析

北美占主导地位页:1活跃的神经刺激市场占收入份额最大的2025年为38.2%在主要神经调节装置制造商的强大存在、先进的保健基础设施、大量采用可植入的神经刺激疗法、以及越来越多地利用VNS技术来治疗癫痫和抗治疗抑郁症等的支持下,上述技术得到了支持。该区域受益于有利的偿还框架、神经系统疾病发病率的上升以及对先进神经技术的持续投资。在临床上越来越多地采用活泼神经刺激装置,同时越来越多地开展以扩大治疗应用为重点的研究活动,继续增强北美在全球市场上的领导地位。

美国真空神经刺激市场透视

这个美国.活跃的神经刺激市场由于对高级神经调节疗法的需求不断增加,癫痫病和抗治疗抑郁症的流行率上升,以及广泛采用可植入的VNS设备,目前正在出现强劲增长。国内已建立完善的医疗保健系统、大型医疗器械公司的存在以及高度关注神经学研究,正在推动市场扩张。此外,增加对创新刺激技术、临床研究和个性化治疗方法的投资,正在支持医院和专科中心采用VNS。

欧洲真空神经刺激市场洞察

这个欧洲活泼的神经刺激市场在先进的医疗保健系统、越来越多地采用神经调节疗法以及日益增长的对神经功能失调替代治疗方案的需求的推动下,全球收入仍然有很大增加。本区域受益于强有力的研究能力、对VNS疗法的认识的提高,以及旨在改善神经病管理的更多保健投资。扩大对癫痫、抑郁和其他新兴应用的活泼神经刺激,正在支持整个欧洲国家的市场增长。

英国真空神经刺激市场透视

这个英国活泼的神经刺激市场越来越多的人采用先进的神经治疗方法,越来越多的保健投资,对最低侵入性神经调节疗法的需求不断增加。该国注重改善神经护理,扩大获得创新医疗技术的机会并增加临床研究活动,这些都有助于市场的发展。此外,保健提供者和病人对VNS疗法的益处的认识日益提高,这正在支持各专业中心和医院的收养。

德国真空神经刺激市场透视

这个德国活泼的神经刺激市场由于其先进的保健基础设施、强大的医疗技术部门以及越来越多地采用创新的神经刺激疗法,正在稳步扩大。神经系统疾病病例不断增加,对有效治疗替代方法的需求日益增加,以及对保健创新的投资增加,这些都正在推动市场增长。此外,德国注重先进的临床研究和采用尖端医疗器械,支持将VNS技术纳入神经治疗路径.

亚太真空神经刺激市场观察

亚太区域的神经刺激市场预计增长最快,从2026年到2033年CAGR增长为8.1%,其驱动力是神经功能失调的日益普遍、获得先进保健技术的机会的增多、保健开支的增加以及越来越多的采用神经调节疗法。诸如中国、印度、日本和韩国等国家由于扩大保健基础设施和提高对替代疗法的认识,对创新神经治疗方法的需求正在增加。此外,专科医院的增长、先进医疗器械的提供增加以及对保健现代化的投资增加正在加速区域市场的扩大。

日本真空神经刺激市场透视

日本的神经刺激市场由于国内先进的医疗保健系统、人口老化、神经病负担日益加重以及医疗创新的强烈关注而持续增长。保健提供者越来越多地采用神经调节技术治疗癫痫、抑郁症和其他神经疾病。此外,日本重视精确医学、先进的医疗器械开发以及改进的病人护理解决方案,这正有助于越来越多地采用VNS疗法。

中国真空神经刺激市场透视

这个中国活泼的神经刺激市场神经系统疾病日益普遍,保健基础设施扩大,保健开支增加,以及日益采用先进的神经调节技术,这些都正在迅速增长。政府为改善医疗保健服务、增加对医疗技术的投资以及扩大专业护理设施而采取的举措正在支持市场增长。此外,对先进神经治疗的认识不断提高,创新医疗器械的提供不断增多,使中国成为全球发展最快的活泼神经刺激技术市场之一。

真空神经刺激市场份额

瓦格斯神经刺激行业主要由名副其实的公司领导,其中包括:

Liva Nova PLC (英国).
梅德罗尼克(爱尔兰)
波士顿科学公司(美国)
Abbott实验室(美国)
Nevro公司(美国)
电子Core股份有限公司(美国)
Setpoint医疗公司(美国)
Inspire医疗系统公司(美国)
生物控制医学(以色列)
MicroTransponder Inc.(美国)
塞尔博梅德股份有限公司(德国)
Parasym有限公司 (英国)
纳鲁医疗股份有限公司(美国)
新轴股份有限公司(美国)
真空神经刺激疗法(美国).
创新健康解决方案(美国).
Neurosigma股份有限公司(美国)
ReShape生命科学公司(美国)
Cyberonics股份有限公司(美国)
Stimwave技术公司(美国)
突触生物医学公司(美国)
GTX 医疗(荷兰)
Neuropace公司(美国)
Axonics股份有限公司(美国)
萨卢达医药有限公司(澳大利亚)
北京PINS医疗有限公司(中国)
江苏奥克森斯医疗技术有限公司(中国)

真空神经刺激市场的最新动态

2021年2月,Electronic Core, Inc.宣布其γCore非侵入性活性神经刺激(nVNS)装置获得FDA 510(k)许可,可被扩大用于12至17岁的青少年,用于急性和预防性的偏头痛治疗. 批准将γCore的临床应用范围扩大到了成年患者之外,并加强了采用非入侵性VNS技术作为偏头痛管理替代治疗选择
2021年9月,MicroTransponder, Inc.的Vivestim-Paired VNS System获得FDA批准进行慢性异性中风康复. 该系统成为FDA批准的首个以活性神经刺激为基础的康复技术,目的是在中风患者与康复疗法相结合时改善上位运动功能. 这一里程碑扩大了VNS技术的作用,超越了癫痫和抑郁等传统神经学应用.
2021年9月,电子Core股份有限公司宣布FDA 510(k)对γCore nVNS进行清关,用于治疗成人的麻痹性肝炎和肝炎. 扩大的指数增加了该装置在罕见头痛症中的应用,并支持在疼痛管理中更广泛地采用非侵入性活性神经刺激解决方案
2023年2月,LivaNova PLC推出了SenTiva DUO,为抗药性癫痫患者所设计的可植入脉冲发生器. 新设备引入了双平顶头配置,允许已存在双平顶VNS的患者在不取代遗留线索的情况下访问更新的VNS治疗技术,改善治疗的可获性和设备相容性.
2024年6月,研究人员推进了活性神经刺激的计算模型方法,以增进对刺激机制的理解并优化处理策略. 新的预测模型研究探索了计算框架如何支持患者反应预测和个性化VNS参数优化,凸显了数字技术在神经调制发展中日益增长的作用.
2025年1月,研究动态继续探索在神经和精神状况中,包括癫痫、抑郁和中风康复等多变性神经刺激的治疗潜力。新出现的科学研究侧重于了解神经途径和VNS行动机制,支持今后在定向和个性化神经调节疗法方面的进步

SKU-54694

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 GLOBAL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL IMPLANTABLE VNS DEVICES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL EXTERNAL VNS DEVICES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL METALLIC IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL POLYMERIC IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL CERAMICS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 9 GLOBAL EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL OTHERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL ADULTS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL GERIATRICS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 25 GLOBAL VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 26 GLOBAL SPECIALTY CENTERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 GLOBAL HOSPITALS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 GLOBAL OTHERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 GLOBAL VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 31 GLOBAL DIRECT TENDER IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 GLOBAL RETAIL SALES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 GLOBAL OTHERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 GLOBAL VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 38 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 39 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 51 U.S. VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 52 U.S. VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 53 U.S. VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 54 U.S. VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 55 U.S. VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 56 U.S. EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 57 U.S. DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 58 U.S. PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 59 U.S. OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 60 U.S. VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 61 U.S. ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 62 U.S. GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 63 U.S. PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 64 U.S. VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 65 U.S. VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 66 CANADA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 67 CANADA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 68 CANADA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 69 CANADA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 70 CANADA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 CANADA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 72 CANADA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 73 CANADA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 74 CANADA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 CANADA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 76 CANADA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 77 CANADA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 78 CANADA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 79 CANADA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 80 CANADA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 81 MEXICO VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 82 MEXICO VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 83 MEXICO VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 84 MEXICO VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 85 MEXICO VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 MEXICO EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 MEXICO DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 MEXICO PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 MEXICO OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 MEXICO VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 91 MEXICO ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 92 MEXICO GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 93 MEXICO PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 94 MEXICO VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 95 MEXICO VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 96 EUROPE VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 97 EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 98 EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 99 EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 100 EUROPE VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 101 EUROPE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 102 EUROPE EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 103 EUROPE DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 104 EUROPE PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 105 EUROPE OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 EUROPE VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 107 EUROPE ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 108 EUROPE GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 109 EUROPE PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 110 EUROPE VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 111 EUROPE VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 112 GERMANY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 113 GERMANY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 114 GERMANY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 115 GERMANY VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 116 GERMANY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 117 GERMANY EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 118 GERMANY DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 119 GERMANY PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 120 GERMANY OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 121 GERMANY VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 122 GERMANY ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 123 GERMANY GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 124 GERMANY PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 125 GERMANY VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 126 GERMANY VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 127 U.K. VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 128 U.K. VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 129 U.K. VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 130 U.K. VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 131 U.K. VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 U.K. EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 U.K. DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 U.K. PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 U.K. OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 U.K. VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 137 U.K. ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 138 U.K. GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 139 U.K. PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 140 U.K. VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 141 U.K. VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 142 ITALY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 143 ITALY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 144 ITALY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 145 ITALY VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 146 ITALY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 147 ITALY EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 148 ITALY DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 149 ITALY PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 150 ITALY OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 151 ITALY VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 152 ITALY ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 153 ITALY GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 154 ITALY PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 155 ITALY VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 156 ITALY VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 157 SPAIN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 158 SPAIN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 159 SPAIN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 160 SPAIN VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 161 SPAIN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 162 SPAIN EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 163 SPAIN DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 164 SPAIN PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 165 SPAIN OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 166 SPAIN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 167 SPAIN ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 168 SPAIN GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 169 SPAIN PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 170 SPAIN VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 171 SPAIN VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 172 FRANCE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 173 FRANCE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 174 FRANCE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 175 FRANCE VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 176 FRANCE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 177 FRANCE EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 178 FRANCE DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 179 FRANCE PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 180 FRANCE OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 181 FRANCE VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 182 FRANCE ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 183 FRANCE GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 184 FRANCE PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 185 FRANCE VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 186 FRANCE VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 187 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 188 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 189 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 190 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 191 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 192 SWITZERLAND EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 193 SWITZERLAND DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 194 SWITZERLAND PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 195 SWITZERLAND OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 196 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 197 SWITZERLAND ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 198 SWITZERLAND GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 199 SWITZERLAND PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 200 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 201 SWITZERLAND VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 202 BELGIUM VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 203 BELGIUM VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 204 BELGIUM VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 205 BELGIUM VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 206 BELGIUM VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 207 BELGIUM EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 208 BELGIUM DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 209 BELGIUM PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 210 BELGIUM OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 211 BELGIUM VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 212 BELGIUM ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 213 BELGIUM GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 214 BELGIUM PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 215 BELGIUM VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 216 BELGIUM VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 217 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 218 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 219 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 220 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 221 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 222 NETHERLANDS EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 223 NETHERLANDS DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 224 NETHERLANDS PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 225 NETHERLANDS OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 226 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 227 NETHERLANDS ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 228 NETHERLANDS GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 229 NETHERLANDS PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 230 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 231 NETHERLANDS VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 232 RUSSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 233 RUSSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 234 RUSSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 235 RUSSIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 236 RUSSIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 237 RUSSIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 238 RUSSIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 239 RUSSIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 240 RUSSIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 241 RUSSIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 242 RUSSIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 243 RUSSIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 244 RUSSIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 245 RUSSIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 246 RUSSIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 247 TURKEY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 248 TURKEY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 249 TURKEY VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 250 TURKEY VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 251 TURKEY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 252 TURKEY EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 253 TURKEY DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 254 TURKEY PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 255 TURKEY OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 256 TURKEY VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 257 TURKEY ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 258 TURKEY GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 259 TURKEY PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 260 TURKEY VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 261 TURKEY VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 262 REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 263 REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 264 REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 265 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 266 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 267 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 268 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 269 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 270 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 271 ASIA-PACIFIC EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 272 ASIA-PACIFIC DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 273 ASIA-PACIFIC PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 274 ASIA-PACIFIC OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 275 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 276 ASIA-PACIFIC ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 277 ASIA-PACIFIC GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 278 ASIA-PACIFIC PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 279 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 280 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 281 CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 282 CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 283 CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 284 CHINA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 285 CHINA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 286 CHINA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 287 CHINA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 288 CHINA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 289 CHINA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 290 CHINA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 291 CHINA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 292 CHINA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 293 CHINA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 294 CHINA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 295 CHINA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 296 JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 297 JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 298 JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 299 JAPAN VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 300 JAPAN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 301 JAPAN EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 302 JAPAN DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 303 JAPAN PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 304 JAPAN OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 305 JAPAN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 306 JAPAN ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 307 JAPAN GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 308 JAPAN PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 309 JAPAN VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 310 JAPAN VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 311 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 312 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 313 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 314 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 315 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 316 SOUTH KOREA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 317 SOUTH KOREA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 318 SOUTH KOREA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 319 SOUTH KOREA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 320 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 321 SOUTH KOREA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 322 SOUTH KOREA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 323 SOUTH KOREA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 324 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 325 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 326 INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 327 INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 328 INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 329 INDIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 330 INDIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 331 INDIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 332 INDIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 333 INDIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 334 INDIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 335 INDIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 336 INDIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 337 INDIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 338 INDIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 339 INDIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 340 INDIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 341 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 342 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 343 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 344 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 345 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 346 AUSTRALIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 347 AUSTRALIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 348 AUSTRALIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 349 AUSTRALIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 350 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 351 AUSTRALIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 352 AUSTRALIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 353 AUSTRALIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 354 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 355 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 356 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 357 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 358 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 359 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 360 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 361 SINGAPORE EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 362 SINGAPORE DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 363 SINGAPORE PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 364 SINGAPORE OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 365 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 366 SINGAPORE ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 367 SINGAPORE GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 368 SINGAPORE PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 369 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 370 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 371 THAILAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 372 THAILAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 373 THAILAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 374 THAILAND VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 375 THAILAND VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 376 THAILAND EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 377 THAILAND DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 378 THAILAND PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 379 THAILAND OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 380 THAILAND VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 381 THAILAND ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 382 THAILAND GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 383 THAILAND PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 384 THAILAND VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 385 THAILAND VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 386 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 387 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 388 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 389 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 390 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 391 MALAYSIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 392 MALAYSIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 393 MALAYSIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 394 MALAYSIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 395 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 396 MALAYSIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 397 MALAYSIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 398 MALAYSIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 399 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 400 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 401 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 402 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 403 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 404 INDONESIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 405 INDONESIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 406 INDONESIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 407 INDONESIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 408 INDONESIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 409 INDONESIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 410 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 411 INDONESIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 412 INDONESIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 413 INDONESIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 414 INDONESIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 415 INDONESIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 416 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 417 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 418 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 419 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 420 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 421 PHILIPPINES EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 422 PHILIPPINES DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 423 PHILIPPINES PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 424 PHILIPPINES OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 425 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 426 PHILIPPINES ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 427 PHILIPPINES GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 428 PHILIPPINES PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 429 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 430 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 431 REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 432 REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 433 REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 434 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 435 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 436 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 437 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 438 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 439 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 440 SOUTH AMERICA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 441 SOUTH AMERICA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 442 SOUTH AMERICA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 443 SOUTH AMERICA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 444 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 445 SOUTH AMERICA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 446 SOUTH AMERICA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 447 SOUTH AMERICA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 448 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 449 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 450 BRAZIL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 451 BRAZIL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 452 BRAZIL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 453 BRAZIL VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 454 BRAZIL VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 455 BRAZIL EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 456 BRAZIL DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 457 BRAZIL PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 458 BRAZIL OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 459 BRAZIL VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 460 BRAZIL ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 461 BRAZIL GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 462 BRAZIL PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 463 BRAZIL VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 464 BRAZIL VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 465 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 466 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 467 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 468 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 469 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 470 ARGENTINA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 471 ARGENTINA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 472 ARGENTINA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 473 ARGENTINA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 474 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 475 ARGENTINA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 476 ARGENTINA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 477 ARGENTINA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 478 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 479 ARGENTINA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 480 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 481 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 482 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 483 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 484 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 485 COLOMBIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 486 COLOMBIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 487 COLOMBIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 488 COLOMBIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 489 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 490 COLOMBIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 491 COLOMBIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 492 COLOMBIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 493 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 494 COLOMBIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 495 REST OF SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 496 REST OF SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 497 REST OF SOUTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 498 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 499 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 500 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 501 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 502 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 503 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 504 MIDDLE EAST AND AFRICA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 505 MIDDLE EAST AND AFRICA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 506 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 507 MIDDLE EAST AND AFRICA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 508 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 509 MIDDLE EAST AND AFRICA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 510 MIDDLE EAST AND AFRICA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 511 MIDDLE EAST AND AFRICA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 512 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 513 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 514 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 515 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 516 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 517 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 518 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 519 SOUTH AFRICA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 520 SOUTH AFRICA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 521 SOUTH AFRICA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 522 SOUTH AFRICA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 523 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 524 SOUTH AFRICA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 525 SOUTH AFRICA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 526 SOUTH AFRICA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 527 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 528 SOUTH AFRICA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 529 UAE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 530 UAE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 531 UAE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 532 UAE VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 533 UAE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 534 UAE EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 535 UAE DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 536 UAE PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 537 UAE OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 538 UAE VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 539 UAE ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 540 UAE GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 541 UAE PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 542 UAE VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 543 UAE VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 544 EGYPT VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 545 EGYPT VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 546 EGYPT VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 547 EGYPT VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 548 EGYPT VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 549 EGYPT EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 550 EGYPT DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 551 EGYPT PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 552 EGYPT OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 553 EGYPT VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 554 EGYPT ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 555 EGYPT GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 556 EGYPT PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 557 EGYPT VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 558 EGYPT VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 559 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 560 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 561 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 562 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 563 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 564 SAUDI ARABIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 565 SAUDI ARABIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 566 SAUDI ARABIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 567 SAUDI ARABIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 568 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 569 SAUDI ARABIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 570 SAUDI ARABIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 571 SAUDI ARABIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 572 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 573 SAUDI ARABIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 574 ISRAEL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 575 ISRAEL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 576 ISRAEL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 577 ISRAEL VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 578 ISRAEL VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 579 ISRAEL EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 580 ISRAEL DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 581 ISRAEL PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 582 ISRAEL OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 583 ISRAEL VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 584 ISRAEL ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 585 ISRAEL GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 586 ISRAEL PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 587 ISRAEL VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 588 ISRAEL VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 589 REST OF MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 590 REST OF MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 591 REST OF MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

图片列表

FIGURE 1 GLOBAL VAGUS NERVE STIMULATION MARKET: SEGMENTATION

FIGURE 2 GLOBAL VAGUS NERVE STIMULATION MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL VAGUS NERVE STIMULATION MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL VAGUS NERVE STIMULATION MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL VAGUS NERVE STIMULATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL VAGUS NERVE STIMULATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL VAGUS NERVE STIMULATION MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL VAGUS NERVE STIMULATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 GLOBAL VAGUS NERVE STIMULATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL VAGUS NERVE STIMULATION MARKET: SEGMENTATION

FIGURE 11 THE GROWING DEMAND FOR INNOVATIVE NON–INVASIVE VAGUS STIMULATION DEVICES AND THE INCREASED PREVALENCE OF NEUROLOGICAL DISORDERS ARE EXPECTED TO DRIVE THE GLOBAL VAGUS NERVE STIMULATION MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 IMPLANTABLE VNS DEVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VAGUS NERVE STIMULATION MARKET IN 2022 & 2029

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL VAGUS NERVE STIMULATION MARKET, NORTH AMERICA IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR VAGUS NERVE STIMULATION MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL VAGUS NERVE STIMULATION MARKET

FIGURE 16 INCIDENCE OF ADULT-ONSET BRAIN DISORDERS IN THE U.S. IN 2021

FIGURE 17 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, 2021

FIGURE 18 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 19 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 20 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 21 GLOBAL VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, 2021

FIGURE 22 GLOBAL VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, 2022-2029 (USD MILLION)

FIGURE 23 GLOBAL VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, CAGR (2022-2029)

FIGURE 24 GLOBAL VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, LIFELINE CURVE

FIGURE 25 GLOBAL VAGUS NERVE STIMULATION MARKET: BY APPLICATION, 2021

FIGURE 26 GLOBAL VAGUS NERVE STIMULATION MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 27 GLOBAL VAGUS NERVE STIMULATION MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 28 GLOBAL VAGUS NERVE STIMULATION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 29 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, 2021

FIGURE 30 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)

FIGURE 31 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, CAGR (2022-2029)

FIGURE 32 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 33 GLOBAL VAGUS NERVE STIMULATION MARKET: BY END USER, 2021

FIGURE 34 GLOBAL VAGUS NERVE STIMULATION MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 35 GLOBAL VAGUS NERVE STIMULATION MARKET: BY END USER, CAGR (2022-2029)

FIGURE 36 GLOBAL VAGUS NERVE STIMULATION MARKET: BY END USER, LIFELINE CURVE

FIGURE 37 GLOBAL VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 38 GLOBAL VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 39 GLOBAL VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 40 GLOBAL VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 41 GLOBAL VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 42 GLOBAL VAGUS NERVE STIMULATION MARKET: BY REGION (2021)

FIGURE 43 GLOBAL VAGUS NERVE STIMULATION MARKET: BY REGION (2022 & 2029)

FIGURE 44 GLOBAL VAGUS NERVE STIMULATION MARKET: BY REGION (2021 & 2029)

FIGURE 45 GLOBAL VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 46 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 47 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021)

FIGURE 48 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2022 & 2029)

FIGURE 49 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021 & 2029)

FIGURE 50 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022 - 2029)

FIGURE 51 EUROPE VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 52 EUROPE VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021)

FIGURE 53 EUROPE VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2022 & 2029)

FIGURE 54 EUROPE VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021 & 2029)

FIGURE 55 EUROPE VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022 - 2029)

FIGURE 56 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 57 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021)

FIGURE 58 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2022 & 2029)

FIGURE 59 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021 & 2029)

FIGURE 60 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022 - 2029)

FIGURE 61 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 62 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021)

FIGURE 63 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2022 & 2029)

FIGURE 64 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021 & 2029)

FIGURE 65 SOUTH AMERICA VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022 - 2029)

FIGURE 66 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 67 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021)

FIGURE 68 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2022 & 2029)

FIGURE 69 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021 & 2029)

FIGURE 70 MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022 - 2029)

FIGURE 71 GLOBAL VAGUS NERVE STIMULATION MARKET: COMPANY SHARE 2021 (%)

FIGURE 72 NORTH AMERICA VAGUS NERVE STIMULATION MARKET: COMPANY SHARE 2021 (%)

FIGURE 73 EUROPE VAGUS NERVE STIMULATION MARKET: COMPANY SHARE 2021 (%)

FIGURE 74 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: COMPANY SHARE 2021 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

常见问题

申请部分是什么?

在应用的基础上,Vagus Nerve刺激市场被分入了抑郁症,癫痫,和米格赖因.

产品部分是什么?

基于产品,Vagus Nerve刺激市场被分入可移植VNS设备,和外置VNS设备.

哪个地区主导市场?

在市场上分析的国家有:美国,加拿大,墨西哥,德国,法国,英国,意大利,西班牙,荷兰,俄罗斯,瑞士,土耳其,比利时,欧洲其他地区,中国,日本,印度,韩国,澳大利亚,新加坡,泰国,马来西亚,印度尼西亚,菲律宾,亚太其他地区,巴西,阿根廷,哥伦比亚,南美洲其他地区,南非,沙特阿拉伯,阿联酋,埃及,以色列,中东和非洲其他地区.

谁是这个市场的顶尖角色?

顶级玩家有:美德通克,利瓦诺瓦PLC,电子Core,Inc.,Cirtec,大脑控制有限公司,Soterix Medical Inc.,SetPoint Medical,MicroTransponder Inc, Parasym Ltd等,以及tVNS Technology GmbH等.

哪个地区主导了瓦格斯神经刺激市场?

北美在Vagus Nerve刺激市场占据了主导地位,2025年收入份额最大,为38.2%,主要神经调节设备制造商的强大存在、先进的保健基础设施、高水平采用可植入神经刺激疗法以及越来越多地使用VNS治疗癫痫和耐治疗抑郁症。本区域还受益于有利的偿还框架、神经系统紊乱率的上升以及对先进神经技术研究的持续投资。

在Vagus Nerve刺激市场,哪个地区增长最快?

2026年至2033年,亚太区域的CAGR增长最快,为8.1%,其主要原因是神经系统疾病日益普遍,获得先进保健技术的机会增加,保健支出增加,中国、印度、日本和韩国等国越来越多地采用神经调节疗法。扩大专科医院,提高对替代神经治疗的认识,进一步加快了市场增长.